Nicole Erin Kinsey White

Array ( [id] => 7579814 [patent_doc_number] => 20110293697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'HIV-1 Immunogenic Compositions' [patent_app_type] => utility [patent_app_number] => 13/081756 [patent_app_country] => US [patent_app_date] => 2011-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15873 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293697.pdf [firstpage_image] =>[orig_patent_app_number] => 13081756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11262236 [patent_doc_number] => 09486517 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-08 [patent_title] => 'Viral particle released after infection of mammalian cells by human cytomegalovirus (HCMV) containing a fusion protein and use thereof' [patent_app_type] => utility [patent_app_number] => 13/639636 [patent_app_country] => US [patent_app_date] => 2011-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7406 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13639636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8430128 [patent_doc_number] => 20120252003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'Bacteria Identification by Phage Induced Impedance Fluctuation Analysis' [patent_app_type] => utility [patent_app_number] => 13/075250 [patent_app_country] => US [patent_app_date] => 2011-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3959 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13075250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9033853 [patent_doc_number] => 20130236491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'SPHERICAL NANO AND MICROPARTICLES DERIVED FROM PLANT VIRUSES FOR THE DISPLAY OF FOREIGN PROTEINS OR EPITOPES' [patent_app_type] => utility [patent_app_number] => 13/877306 [patent_app_country] => US [patent_app_date] => 2011-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12287 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936638 [patent_doc_number] => 20110212434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'NOVEL HIV-BASED RECOMBINANT VIRAL CLONES AND USE THEREOF IN ANALYTICAL METHODS' [patent_app_type] => utility [patent_app_number] => 13/015842 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17777 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212434.pdf [firstpage_image] =>[orig_patent_app_number] => 13015842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958927 [patent_doc_number] => 20110183314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'BACTERIOPHAGE-BASED MICROORGANISM DIAGNOSTIC ASSAY USING SPEED OR ACCELERATION OF BACTERIOPHAGE REPRODUCTION' [patent_app_type] => utility [patent_app_number] => 13/014631 [patent_app_country] => US [patent_app_date] => 2011-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3713 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183314.pdf [firstpage_image] =>[orig_patent_app_number] => 13014631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000701 [patent_doc_number] => 20110117101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'CC CHEMOKINE RECEPTOR 5 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 13/012482 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20676 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117101.pdf [firstpage_image] =>[orig_patent_app_number] => 13012482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174363 [patent_doc_number] => 20110177090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'Glycan markers and autoantibody signatures in HIV-1 and HIV-1-associated malignancies' [patent_app_type] => utility [patent_app_number] => 13/009474 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10310 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177090.pdf [firstpage_image] =>[orig_patent_app_number] => 13009474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187869 [patent_doc_number] => 20110171248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'SYNTHETIC VIRUS-LIKE PARTICLES CONJUGATED TO HUMAN PAPILLOMAVIRUS CAPSID PEPTIDES FOR USE AS VACCINES' [patent_app_type] => utility [patent_app_number] => 12/986874 [patent_app_country] => US [patent_app_date] => 2011-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18957 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171248.pdf [firstpage_image] =>[orig_patent_app_number] => 12986874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9771165 [patent_doc_number] => 20140294828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'ALPHABODIES SPECIFICALLY BINDING TO VIRAL PROTEINS AND METHODS FOR PRODUCING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/994106 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30033 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656454 [patent_doc_number] => 20110305723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Molecular Antigen Array' [patent_app_type] => utility [patent_app_number] => 12/978365 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 86079 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305723.pdf [firstpage_image] =>[orig_patent_app_number] => 12978365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944042 [patent_doc_number] => 20110104662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Methods of Detecting Inhibitors of VIF-Mediated APOBEC3G Degradation and HIV' [patent_app_type] => utility [patent_app_number] => 12/948108 [patent_app_country] => US [patent_app_date] => 2010-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 8426 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104662.pdf [firstpage_image] =>[orig_patent_app_number] => 12948108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6128541 [patent_doc_number] => 20110087005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'HLA-BINDING PEPTIDE, PRECURSOR THEREOF, AND DNA FRAGMENT AND RECOMBINANT VECTOR CODING FOR SAID HLA-BINDING PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/947624 [patent_app_country] => US [patent_app_date] => 2010-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8327 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20110087005.pdf [firstpage_image] =>[orig_patent_app_number] => 12947624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8358660 [patent_doc_number] => 20120213820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'Pharmaceutical composition for the treatment and prevention of a rhinovirus infection' [patent_app_type] => utility [patent_app_number] => 13/504766 [patent_app_country] => US [patent_app_date] => 2010-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13895 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944169 [patent_doc_number] => 20110104789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'NON-INTEGRATING REV-DEPENDENT LENTIVIRAL VECTOR AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/916849 [patent_app_country] => US [patent_app_date] => 2010-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15960 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104789.pdf [firstpage_image] =>[orig_patent_app_number] => 12916849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8452803 [patent_doc_number] => 20120263750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'RECOMBINANT MODIFIED VACCINIA ANKARA (MVA) VACCINIA VIRUS CONTAINING RESTRUCTURED INSERTION SITES' [patent_app_type] => utility [patent_app_number] => 13/502205 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 23566 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943680 [patent_doc_number] => 20110104300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Methods for Screening Chemical, Biological, and Physical Agents for Disinfecting Infectious Norovirus' [patent_app_type] => utility [patent_app_number] => 12/892505 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6705 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104300.pdf [firstpage_image] =>[orig_patent_app_number] => 12892505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6031114 [patent_doc_number] => 20110081377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'AEROSOLIZED GENETIC VACCINES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/887286 [patent_app_country] => US [patent_app_date] => 2010-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 28834 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081377.pdf [firstpage_image] =>[orig_patent_app_number] => 12887286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5975843 [patent_doc_number] => 20110070217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING HIV INFECTION WITH CUPREDOXIN AND CYTOCHROME C' [patent_app_type] => utility [patent_app_number] => 12/880682 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18928 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070217.pdf [firstpage_image] =>[orig_patent_app_number] => 12880682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270376 [patent_doc_number] => 08211879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Cationic steroid antimicrobial compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 12/876993 [patent_app_country] => US [patent_app_date] => 2010-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 42675 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12876993 [rel_patent_id] =>[rel_patent_doc_number] =>)